Abstract Pentraxin-3 (PTX3) is an acute phase protein (APP) and a member of the long
pentraxin family that is recognised for its role in peripheral immunity and vascular …

Ischemic stroke is a leading cause of death and long‐term disability worldwide, yet
availability of current treatments is limited. The downstream events resulting from cerebral …

Background Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …

Restoration of cerebral blood flow (CBF) and upregulation of angiogenesis are crucial for
brain repair and functional recovery after cerebral ischaemia. Pentraxin 3 (PTX3) is a key …

Background Although current therapy for patients with early-stage squamous cell carcinoma
of the head and neck (SCCHN) is potentially curative, the recurrence rate is high. Patients …

Experimental cerebral malaria (ECM) is a gamma interferon (IFN-γ)-dependent syndrome.
However, whether IFN-γ promotes ECM through direct and synergistic targeting of multiple …

In this paper, we study the drivers of permanent and transitory deposit dollarization for a
sample of CESE countries using panel cointegration techniques. The results suggest that a …

Introduction: The acute phase protein pentraxin 3 (PTX3) is known for its anti-inflammatory
effects through downregulating neutrophil transmigration during peripheral inflammation …

Background This study examined real-world treatment and management of bacillus
Calmette-Guérin (BCG)-unresponsive patients across 3 continents, including patients …

Objective To examine real-world treatment persistence, colectomy-free survival and
treatment switching patterns in UK patients with ulcerative colitis (UC) prescribed golimumab …